Soleno Therapeutics (SLNO) Cash from Operations (2013 - 2026)
Soleno Therapeutics (SLNO) reported Cash from Operations of 25980000.0 for Q1 2026, up 179.32% year-over-year from 9301046.74 in Q1 2025, and down 46.66% on a QoQ basis from 48704000.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Cash from Operations data on file, last reported at 25980000.0 in Q1 2026.
- Quarterly Cash from Operations rose 179.32% year-over-year to 25980000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 105530000.0 (up 218.15% YoY) and the FY2025 annual result came in at 46798000.0, up 167.73% from the prior year.
- Cash from Operations declined to 25980000.0 in Q1 2026 per SLNO's latest filing, from 48704000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 48704000.0 in Q4 2025 and bottomed at 32752000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 6332000.0 (2023), against an average of 2472882.35.
- The widest annual swing landed in 2024, when Cash from Operations tumbled 279.97%; it then surged 391.4% in 2025.
- Tracing SLNO's Cash from Operations over 5 years: stood at 5143000.0 in 2022, then retreated by 22.77% to 6314000.0 in 2023, then plunged by 279.97% to 23991000.0 in 2024, then surged by 303.01% to 48704000.0 in 2025, then slumped by 46.66% to 25980000.0 in 2026.
- Per Business Quant, the three latest SLNO Cash from Operations figures stand at 25980000.0 (Q1 2026), 48704000.0 (Q4 2025), and 43494000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 25.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.98 Mn |
| Mar 31, 2026 | 25.98 Mn |
| Dec 31, 2025 | 48.70 Mn |
| Dec 31, 2025 | 48.70 Mn |
| Sep 30, 2025 | 43.49 Mn |
| Sep 30, 2025 | 43.49 Mn |
| Jun 30, 2025 | -12.65 Mn |
| Jun 30, 2025 | -12.65 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Mar 31, 2025 | -32.75 Mn |
| Dec 31, 2024 | -23.99 Mn |
| Dec 31, 2024 | -23.99 Mn |
| Sep 30, 2024 | -14.93 Mn |
| Sep 30, 2024 | -14.93 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Mar 31, 2024 | -12.53 Mn |
| Mar 31, 2024 | -12.53 Mn |
| Dec 31, 2023 | -6.31 Mn |
| Dec 31, 2023 | -6.31 Mn |
| Sep 30, 2023 | -6.33 Mn |
| Sep 30, 2023 | -6.33 Mn |
| Jun 30, 2023 | -5.57 Mn |
| Jun 30, 2023 | -5.57 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Dec 31, 2022 | -5.14 Mn |
| Dec 31, 2022 | -5.14 Mn |
| Sep 30, 2022 | -4.66 Mn |
| Sep 30, 2022 | -4.66 Mn |
| Jun 30, 2022 | -4.62 Mn |
| Jun 30, 2022 | -4.62 Mn |
| Mar 31, 2022 | -6.36 Mn |
| Mar 31, 2022 | -6.36 Mn |
| Dec 31, 2021 | -6.86 Mn |
| Dec 31, 2021 | -6.86 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Jun 30, 2021 | -8.01 Mn |
| Jun 30, 2021 | -8.01 Mn |
| Mar 31, 2021 | -7.49 Mn |
| Mar 31, 2021 | -7.49 Mn |
| Dec 31, 2020 | -6.87 Mn |
| Dec 31, 2020 | -6.87 Mn |
| Sep 30, 2020 | -6.16 Mn |
| Sep 30, 2020 | -6.16 Mn |
| Jun 30, 2020 | -6.53 Mn |
| Jun 30, 2020 | -6.53 Mn |
| Mar 31, 2020 | -5.66 Mn |
| Mar 31, 2020 | -5.66 Mn |
| Dec 31, 2019 | -5.08 Mn |
| Dec 31, 2019 | -5.08 Mn |
| Sep 30, 2019 | -4.72 Mn |
| Sep 30, 2019 | -4.72 Mn |
| Jun 30, 2019 | -3.89 Mn |
| Jun 30, 2019 | -3.89 Mn |
| Mar 31, 2019 | -3.69 Mn |
| Mar 31, 2019 | -3.69 Mn |
| Dec 31, 2018 | -3.74 Mn |
| Dec 31, 2018 | -3.74 Mn |
| Sep 30, 2018 | -2.68 Mn |
| Sep 30, 2018 | -2.68 Mn |
| Jun 30, 2018 | -2.75 Mn |
| Jun 30, 2018 | -2.75 Mn |
| Mar 31, 2018 | -2.52 Mn |
| Mar 31, 2018 | -2.52 Mn |
| Dec 31, 2017 | 299,000.00 |
| Dec 31, 2017 | 299,000.00 |
| Sep 30, 2017 | -3.78 Mn |
| Sep 30, 2017 | -3.78 Mn |
| Jun 30, 2017 | -1.26 Mn |
| Jun 30, 2017 | -1.26 Mn |
| Mar 31, 2017 | -2.18 Mn |
| Mar 31, 2017 | -2.18 Mn |
| Dec 31, 2016 | -1.30 Mn |
| Dec 31, 2016 | -1.30 Mn |
| Sep 30, 2016 | 2.07 Mn |
| Sep 30, 2016 | 2.07 Mn |
| Jun 30, 2016 | -4.04 Mn |
| Jun 30, 2016 | -4.04 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Dec 31, 2015 | -3.38 Mn |
| Dec 31, 2015 | -3.38 Mn |
| Sep 30, 2015 | -2.86 Mn |
| Sep 30, 2015 | -2.86 Mn |
| Jun 30, 2015 | -2.25 Mn |
| Jun 30, 2015 | -2.25 Mn |
| Mar 31, 2015 | -1.81 Mn |
| Mar 31, 2015 | -1.81 Mn |
| Dec 31, 2014 | -1.56 Mn |
| Dec 31, 2014 | -1.56 Mn |
| Sep 30, 2014 | -1.26 Mn |
| Sep 30, 2014 | -1.26 Mn |
| Jun 30, 2014 | -1.16 Mn |
| Jun 30, 2014 | -1.16 Mn |
| Mar 31, 2014 | -509,000.00 |
| Mar 31, 2014 | -509,000.00 |
| Dec 31, 2013 | -722,218.00 |
| Dec 31, 2013 | -722,218.00 |